BridgeMD
New treatment option for Schizophrenia Disorders
Official title Visual Perception in Schizophrenia
ClinicalTrials.gov ID: NCT06911931
What this study is testing
- What it's testing
- This study aims to identify novel markers of psychosis using electroencephalography (EEG).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- All people
- Aged 18-65
- 20/32 visual acuity or better (using in-house optical correction, if necessary)
- An ability to speak English well enough to complete study assessments and to consent to the study
- people with Schizophrenia-Spectrum Disorder
You likely can't join if
- All people
- Presence of characteristics that could impair one's ability to comprehend the nature of the study, provide informed consent, or understand the...
- Subject cannot read and understand the instructions well enough to complete the tasks or cannot provide informed consent.
- Intellectual impairment (WRAT-5 score \< 70) (at the discretion of experimenter);
- Actively intoxicated, as shown via patient self-report or staff report;
- Substance use disorder in the past 3 months;
See the full eligibility criteria
- All people
- Aged 18-65
- 20/32 visual acuity or better (using in-house optical correction, if necessary)
- An ability to speak English well enough to complete study assessments and to consent to the study
- people with Schizophrenia-Spectrum Disorder
- Meets DSM-5 diagnostic criteria for schizophrenia, schizoaffective disorder, or schizophreniform disorder as confirmed by the Structured Interview for DSM-5 (SCID-5).
- people with Bipolar Disorder
- Meets DSM-5 diagnostic criteria for bipolar disorder (type I, II, or unspecified) as confirmed by the Structured Interview for DSM-5 (SCID-5).
- All people
- Presence of characteristics that could impair one's ability to comprehend the nature of the study, provide informed consent, or understand the assessment questions, including the following:
- Subject cannot read and understand the instructions well enough to complete the tasks or cannot provide informed consent.
- Intellectual impairment (WRAT-5 score \< 70) (at the discretion of experimenter);
- Actively intoxicated, as shown via patient self-report or staff report;
- Substance use disorder in the past 3 months;
- Subject considered high risk for suicidal acts (i.e., active suicidal ideation as determined by clinical interview OR any suicide attempt in 30 days prior to screening);
- Subject violence (involving severe/lethal means or violence occurring in prior 6 months) or extreme agitation.
- Being in a current manic state
- Head injury with loss of consciousness greater than 10 minutes (at the discretion of the experimenter).
- Subject has had electroconvulsive therapy (ECT) in the past 8 weeks;
- Diagnosed with a neurological condition (tumor, stroke, brain injury) or neurological disorder, including seizure disorders. Diagnosed with pervasive developmental disorder (phone screen or medical records)
- Lazy eye or squint or other known ocular pathology
- Healthy Control people
- Any lifetime psychotic disorder or history of psychiatric hospitalization (self disclosure);
- Daily antidepressant, mood stabilizer or antipsychotic medication use in the last 6 months, or benzodiazepine use during the prior 2 days (self-disclosure); iii. First-degree relative(s) with a schizophrenia spectrum...
- Case-match Control Non-ill people
- Any lifetime psychotic disorder (as assessed by SCID/or SSD);
- Recurrent depressive episodes or being in a current depressive episode (as assessed by SCID/or SSD)
- Persistent threshold psychotic symptoms
- History of psychiatric hospitalization;
- Daily antidepressant, mood stabilizer or antipsychotic medication use in the last 6 months, or benzodiazepine use during the prior 2 days
- First-degree relative(s) with a schizophrenia spectrum disorder (based on subject self-report) or bipolar disorder.
- Bipolar people
- Persistent threshold psychotic symptoms
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.